Following the recent Institute of Medicine report recommending a replacement of the Food and Drug Administration's 510(k) process for approving medical devices, John Smith, a partner in the law firm Hogan Lovells, sent out a client alert outlining his thoughts.

In a nutshell, Smith finds the IOM's conclusions unrealistic and based on false assumptions, but with some recommendations of value. Here are his thoughts:

Register or login for access to this item and much more

All Health Data Management content is archived after seven days.

Community members receive:
  • All recent and archived articles
  • Conference offers and updates
  • A full menu of enewsletter options
  • Web seminars, white papers, ebooks

Don't have an account? Register for Free Unlimited Access